Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Targeting psychosocial factors can help reduce self-stigma in people with chronic skin diseases.

We need better research to improve alopecia treatment and patient care.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Interleukin-6 may play a role in causing alopecia areata.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

These gene variations are not linked to alopecia areata in Egyptians.

The MPV/PC ratio can help assess disease activity in alopecia areata.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

Topical caffeine improves hair loss intensity, speed, and shedding, and works better with minoxidil/azelaic acid.

Trichoscopy is crucial for accurately diagnosing fibrosing alopecia in pattern distribution.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

Receding hairlines in men are uneven, with the right side larger than the left.

New alopecia treatments aim for better results and fewer side effects.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Carboxytherapy may help increase hair growth in alopecia patients but requires ongoing treatment.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Stress can trigger or worsen alopecia areata.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Tailored combination therapy improves non-scarring alopecia outcomes.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.